A detailed history of Pathstone Holdings, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 32,878 shares of NTRA stock, worth $5.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
32,878
Previous 34,754 5.4%
Holding current value
$5.5 Million
Previous $3.76 Million 11.03%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$97.75 - $129.67 $183,379 - $243,260
-1,876 Reduced 5.4%
32,878 $4.18 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $496,670 - $655,782
5,824 Added 20.13%
34,754 $3.76 Million
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $1.42 Million - $2.23 Million
24,002 Added 487.05%
28,930 $2.65 Million
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $185,046 - $308,689
4,928 New
4,928 $308,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.